Australia, May 27 -- GlaxoSmithKline Biologicals S.A, owns the trademark (2509835) for 'AYRFLUMO' till Nov. 14, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: March 19
Registration Advertised: May 26
For further details contact Davies Collison Cave Pty. Ltd. and AWA Benelux SA.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2509835.
Disclaimer: Curated by HT Syndication....